

NCT01815580 Raw comparison:

Summary:
CHIA has 13 criteria while your personal folder has 21 criteria
Total found criteria: 12/13
Total not Found: 1/13
Total Extra: 8
This trial is INVALID



╒═══════════════════════════════════════════════════╤═══════════════════════════════════════════════════╕
│ CHIA Criteria                                     │ Matching Personal Criteria                        │
╞═══════════════════════════════════════════════════╪═══════════════════════════════════════════════════╡
│ Adult men who have sex with men and transgender   │ Adult men who have sex with men and transgender   │
│ women                                             │ women                                             │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Unaware of HIV status at enrollment in follow-up  │ Unaware of HIV status at enrollment in follow-up  │
│ cohort                                            │ cohort                                            │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ High risk for HIV infection                       │ High risk for HIV infection                       │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Willing to test for HIV                           │ Willing to test for HIV                           │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ No prior ART including prior administration of    │ No prior ART including prior administration of    │
│ pre- and post-exposure prophylaxis in the last 30 │ pre- and post-exposure prophylaxis in the last 30 │
│ days                                              │ days                                              │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Willing to provide informed consent               │ Willing to provide informed consent               │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Prior receipt of investigational anti-HIV vaccine │ Prior receipt of investigational anti-HIV vaccine │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Known allergy/sensitivity or any hypersensitivity │ Known allergy/sensitivity or any hypersensitivity │
│ to components of study drugs (ART) or their       │ to components of study drugs (ART) or their       │
│ formulations                                      │ formulations                                      │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Active drug or alcohol use or dependence that     │ Active drug or alcohol use or dependence that     │
│ would interfere with adherence to study           │ would interfere with adherence to study           │
│ requirements                                      │ requirements                                      │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Serious medical or psychiatric illness that would │ Serious medical or psychiatric illness that would │
│ interfere with the ability to adhere to study     │ interfere with the ability to adhere to study     │
│ requirements                                      │ requirements                                      │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Chronic or acute hepatitis B infection            │ Chronic or acute hepatitis B infection            │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Use of female hormonal products based on estrogen │ Use of female hormonal products based on estrogen │
│ or derivatives                                    │ or derivatives                                    │
╘═══════════════════════════════════════════════════╧═══════════════════════════════════════════════════╛



╒════════════════════════════════════════════════════════════════════════════════════════════════════╕
│ CHIA Criteria Not Found in Personal                                                                │
╞════════════════════════════════════════════════════════════════════════════════════════════════════╡
│ Ongoing therapy with any of the following Systemic corticosteroids Short course less than or equal │
│ to 21 days of corticosteroids is allowed Systemic chemotherapeutic agents Nephrotoxic systemic     │
│ agents including aminoglycosides amphotericin B cidofovir cisplatin foscarnet pentamidine          │
│ Immunomodulatory treatments including Interleukin-2 Investigational agents                         │
╘════════════════════════════════════════════════════════════════════════════════════════════════════╛



╒════════════════════════════════════════════════════════════════════════════════════════════════════╕
│ Extra Personal Criteria                                                                            │
╞════════════════════════════════════════════════════════════════════════════════════════════════════╡
│ Investigational agents                                                                             │
├────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Ongoing therapy with any of the following                                                          │
├────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Immunomodulatory treatments including Interleukin-2                                                │
├────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Nephrotoxic systemic agents including aminoglycosides amphotericin B cidofovir cisplatin foscarnet │
│ pentamidine                                                                                        │
├────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Must be MALE                                                                                       │
├────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Must have minimum age of 18 Years                                                                  │
├────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Systemic chemotherapeutic agents                                                                   │
├────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Systemic corticosteroids Short course less than or equal to 21 days of corticosteroids is allowed  │
╘════════════════════════════════════════════════════════════════════════════════════════════════════╛